Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen B Pouwels

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Nature Communications|October 30, 2021
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Nature Microbiology|July 22, 2021
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United KingdomJia Wei, Nicole Stoesser, Philippa C Matthews, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Nature Medicine|August 28, 2024
Health and economic impacts of Lassa vaccination campaigns in West AfricaDavid R M Smith, Joanne Turner, Patrick Fahr, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Health and economic impacts of Lassa vaccination campaigns in West AfricaDavid R M Smith, Joanne Turner, Patrick Fahr, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 22, 2024
Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodiesNasreen Hassoun-Kheir, Mariana Guedes, Fabiana Arieti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
BMC Public Health|November 29, 2025
U.S. public perceptions on whether risk of dementia and stroke can be modified through maintaining or changing lifestyleJasper R Senff, Mark Jun Shah-Ostrowski, Reinier W P Tack, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Nature Communications|October 30, 2021
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Nature Microbiology|July 22, 2021
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United KingdomJia Wei, Nicole Stoesser, Philippa C Matthews, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Nature Medicine|August 28, 2024
Health and economic impacts of Lassa vaccination campaigns in West AfricaDavid R M Smith, Joanne Turner, Patrick Fahr, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Health and economic impacts of Lassa vaccination campaigns in West AfricaDavid R M Smith, Joanne Turner, Patrick Fahr, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 22, 2024
Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodiesNasreen Hassoun-Kheir, Mariana Guedes, Fabiana Arieti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
BMC Public Health|November 29, 2025
U.S. public perceptions on whether risk of dementia and stroke can be modified through maintaining or changing lifestyleJasper R Senff, Mark Jun Shah-Ostrowski, Reinier W P Tack, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Pageof 11